InsidersTradesSigma
基于 1 个已确定 T+90 收益的买入信号。收益基准：公布次日的收盘价。
无可用的信号评分。
Discover the complete record of transactions filed by Auberton-Herve Andre-Jacques, 董事. Officer active across 2 companies, notably Chavant Capital Acquisition Corp.. In total, 7 reports have been recorded. Split: 1 buy · 0 sell. Activity tracked since 24 February 2022. The latest transaction was disclosed on 21 December 2023 (Attribution). Regulator: SEC (Form 4). All data is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
7 条申报中的 7 条
AUBERTON-HERVE ANDRE-JACQUES is Administrateur at Bionik Laboratories Corp. and Chavant Capital Acquisition Corp. He has 7 filings in total, and across the 7 sampled filings the period runs from 2022-02-28 to 2023-12-26, with the modal transaction nature shown as Attribution.